Loading…
Servier is a global pharmaceutical company focused on therapeutic areas including hypertension, oncology, and rare diseases. The company emphasizes patient partnership and innovation, as seen in its acquisition of Day One Biopharmaceuticals to strengthen its rare cancer portfolio.
AI named Servier Ventures in February 2026.